Literature DB >> 7376077

Immunosuppression by hyperbaric oxygen.

J F Hansbrough, J G Piacentine, B Eiseman.   

Abstract

Reports from several laboratories have indicated that hyperbaric oxygen might be immunosuppressive in animals. We examined the effect of hyperbaric oxygen on a well-studied model of cell-mediated immunity in the mouse, contact sensitivity to dinitrofluorobenzene (DNFB). Using this model, we showed that daily 5-hour exposure of mice to 2.5 ATA hyperbaric oxygen was markedly immunosuppressive. Immunosuppression occurred when mice were exposed to hyperbaric oxygen (HBOX) for 4 days daily before DNFB sensitization or for 5 days daily after sensitization. The immunosuppression was reversed by intravenous administration of 2 x 10(7) peritoneal exudate cells from syngeneic mice, but was not reversed by 5 x 10(7) lymph node cells intravenously. We showed that daily HBOX exposure resulted in a dramatic decrease in circulating total leukocytes and lymphocytes in spleen weight, and in DNA synthesis in draining lymph nodes of sensitized mice. Serum cortisol levels were only marginally elevated in HBOX-treated mice.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7376077

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  9 in total

1.  Hyperbaric oxygen therapy and liver transplantation.

Authors:  Vijayaragavan Muralidharan; Chris Christophi
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

2.  Wound healing from a cellular stress response perspective.

Authors:  Bindi M Doshi; George A Perdrizet; Lawrence E Hightower
Journal:  Cell Stress Chaperones       Date:  2008-07-15       Impact factor: 3.667

3.  Studies on regional cerebral oxygen utilisation and cognitive function in multiple sclerosis.

Authors:  D J Brooks; K L Leenders; G Head; J Marshall; N J Legg; T Jones
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-11       Impact factor: 10.154

Review 4.  Hyperbaric oxygen for patients with multiple sclerosis.

Authors:  J Mertin; W I McDonald
Journal:  Br Med J (Clin Res Ed)       Date:  1984-03-31

5.  Hyperbaric oxygen treatment attenuates the pro-inflammatory and immune responses in apolipoprotein E knockout mice.

Authors:  Bhalchandra Kudchodkar; Harlan Jones; Jerry Simecka; Ladislav Dory
Journal:  Clin Immunol       Date:  2008-07-02       Impact factor: 3.969

6.  Immunological treatment of multiple sclerosis.

Authors:  R A Hughes
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

7.  Exposure to hyperbaric oxygen induces tumour necrosis factor-alpha (TNF-alpha) secretion from rat macrophages.

Authors:  N Lahat; H Bitterman; N Yaniv; A Kinarty; N Bitterman
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

8.  Does living donor hyperoxia have an impact on kidney graft function after transplantation?

Authors:  Zohreh Rostami; Behzad Einollahi; Mohammad Hassan Ghadiani
Journal:  Nephrourol Mon       Date:  2013-06-19

9.  Anti-Inflammatory Effects of Hyperbaric Oxygenation during DSS-Induced Colitis in BALB/c Mice Include Changes in Gene Expression of HIF-1α, Proinflammatory Cytokines, and Antioxidative Enzymes.

Authors:  Sanja Novak; Ines Drenjancevic; Rosemary Vukovic; Zoltán Kellermayer; Anita Cosic; Maja Tolusic Levak; Péter Balogh; Filip Culo; Martina Mihalj
Journal:  Mediators Inflamm       Date:  2016-08-30       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.